Clinical Trial: To Evaluate the Efficacy and Safety of 'BRDE33-100' for the Temporary Correction of Moderate to Severe Nasolabial Folds

U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07069920) titled 'To Evaluate the Efficacy and Safety of 'BRDE33-100' for the Temporary Correction of Moderate to Severe Nasolabial Folds' on July 08.

Brief Summary: This study aims to demonstrate the non-inferiority of BRDE33-100 to Soonsoofill in temporarily improving moderate to severe nasolabial folds.

Study Start Date: Nov. 14, 2024

Study Type: INTERVENTIONAL

Condition: Nasolabial Folds

Intervention: DEVICE: BRDE33-100

BRDE33-100 will be injected once at Visit 2 (Baseline).

DEVICE: Soonsoofill

Soonsoofill will be injected once at Visit 2 (Baseline).

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: BRPharm Co., Ltd.

Published by HT ...